Widely used:Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹1,267 Cr
P/E Ratio
27.46
P/B Ratio
3.05
Industry P/E
35.02
Debt to Equity
0.25
ROE
12.14 %
ROCE
13.89 %
Div. Yield
0.36 %
Book Value
45.1
EPS
5.01
CFO
₹192.00 Cr
EBITDA
₹415.04 Cr
Net Profit
₹264.82 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Themis Medicare
| -47.21 | -12.13 | -44.53 | -34.63 | 15.06 | 34.24 | 26.01 |
|
BSE Healthcare
| -5.22 | 1.63 | -0.78 | 23.77 | 20.16 | 23.01 | 9.89 |
|
BSE Small Cap
| -9.97 | 4.29 | -3.75 | 6.10 | 19.03 | 35.54 | 15.87 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Themis Medicare
| 19.93 | 57.72 | 43.54 | 162.28 | 8.56 | -3.82 | -52.46 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 | 32.11 | -6.85 | -23.41 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 751.25 | 6,679.32 | 26.79 | 13.8 | |
| 2,190.10 | 9,011.72 | 74.24 | 12.96 | |
| 419.00 | 5,141.64 | 68.95 | 6.24 | |
| 907.85 | 5,221.77 | 40.99 | 14.76 |
No Review & Analysis are available.
Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. The company offers active pharmaceutical ingredients (APIs) and formulations for use in various therapeutic areas,... including anti-tuberculosis, anti-malarials, cardiology, pain management, anti-infectives, haematinics, health and nutrition, anaesthesia, gynecology, and orthopedics. It also offers anti-inflammatory drugs and other drugs. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001. Themis Medicare Limited was founded in 1952 and is headquartered in Mumbai, India. Read more
Incorporated
1969
Chairman
Dinesh S Patel
Managing Director
Sachin D Patel
Headquarters
Vapi, Gujarat
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Themis Medicare Ltd stood at ₹ 602 Cr as on 31-Dec-24
The share price of Themis Medicare Ltd is ₹139.14 (NSE) and ₹139.10 (BSE) as of 24-Apr-2025 09:54 IST. Themis Medicare Ltd has given a return of 15.06% in the last 3 years.
Themis Medicare Ltd has a market capitalisation of ₹ 1,267 Cr as on 23-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Themis Medicare Ltd is 3.05 times as on 23-Apr-2025, a 19% discount to its peers’ median range of 3.75 times.
The P/E ratio of Themis Medicare Ltd is 27.46 times as on 23-Apr-2025, a 22% discount to its peers’ median range of 35.02 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Themis Medicare Ltd and enter the required number of quantities and click on buy to purchase the shares of Themis Medicare Ltd.
Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. The company offers active pharmaceutical ingredients (APIs) and formulations for use in various therapeutic areas, including anti-tuberculosis, anti-malarials, cardiology, pain management, anti-infectives, haematinics, health and nutrition, anaesthesia, gynecology, and orthopedics. It also offers anti-inflammatory drugs and other drugs. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001. Themis Medicare Limited was founded in 1952 and is headquartered in Mumbai, India.
The prominent promoters of Themis Medicare Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
Vividhmargi Investments Pvt |
15.78%
|
|
Gedeon Richter Investment Management Ltd. |
9.61%
|
|
Dinesh Shantilal Patel |
9.47%
|
|
Vividh Distributors Pvt Ltd |
7.78%
|
|
Jayshree D Patel |
7.25%
|
The chairman of the company is Dinesh S Patel, and the managing director is Sachin D Patel.
The promoters of Themis Medicare Ltd have pledged 1.63% of the total equity as on Mar-25.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
9,512
|
|
|
6,653
|
|
|
5,320
|
|
|
5,217
|
| Themis Medicare Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
11.69
|
|
Operating margin(%)
|
12.44
|
|
Net Margin(%)
|
7.97
|
|
Dividend yield(%)
|
0.36
|
Yes, TTM profit after tax of Themis Medicare Ltd was ₹46 Cr.
₹1.56
(
